Search results for "ACTIVATOR"

showing 10 items of 488 documents

A High-Throughput Mechanical Activator for Cartilage Engineering Enables Rapid Screening of in vitro Response of Tissue Models to Physiological and S…

2021

Articular cartilage is crucially influenced by loading during development, health, and disease. However, our knowledge of the mechanical conditions that promote engineered cartilage maturation or tissue repair is still incomplete. Current in vitro models that allow precise control of the local mechanical environment have been dramatically limited by very low throughput, usually just a few specimens per experiment. To overcome this constraint, we have developed a new device for the high throughput compressive loading of tissue constructs: the High Throughput Mechanical Activator for Cartilage Engineering (HiT-MACE), which allows the mechanoactivation of 6 times more samples than current tech…

Settore ING-IND/24 - Principi Di Ingegneria ChimicaHistologyAnabolismActivator (genetics)ChemistryCartilageCartilage In vitro model Mechanical activation Mechanobiology Post-traumatic osteoarthritisSettore ING-IND/34 - Bioingegneria IndustrialeOsteoarthritismedicine.diseaseIn vitroIn vitro modelMechanobiologymedicine.anatomical_structuremedicineAnatomyThroughput (business)Biomedical engineeringCells, tissues, organs
researchProduct

Enhancement of lysine acetylation accelerates wound repair

2013

In physiopathological conditions, such as diabetes, wound healing is significantly compromised and chronic complications, including ulcers, may occur. In a mouse model of skin repair, we recently reported that wound treatment with Sirtuin activators and class I HDAC inhibitors induced keratinocyte proliferation and enhanced healing via a nitric oxide (NO) dependent mechanism. We observed an increase in total protein acetylation in the wound area, as determined by acetylation of α-tubulin and histone H3 Lysine 9. We reasoned that this process activated cell function as well as regulated gene expression to foster tissue repair. We report here that the direct activation of P300/CBP-associated …

Skin repairWound HealingepigeneticsActivator (genetics)Short CommunicationkeratinocyteBiologyNitric OxideCell biologyHistone H3medicine.anatomical_structureepigenetics; pathology Wound Healing; lysine acetylation; PCAF; keratinocyte; Nitric OxideBiochemistryPCAFAcetylationPCAFSirtuinmedicinebiology.proteinpathologyGeneral Agricultural and Biological SciencesKeratinocyteWound healinglysine acetylationCommunicative & Integrative Biology
researchProduct

The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma

2021

The multikinase inhibitor sorafenib was the first drug approved by the FDA for treating patients with advanced hepatocellular carcinoma (HCC). However, sorafenib resistance remains a major challenge for improving the effectiveness of HCC treatment. Previously, we identified several genes modulated after sorafenib treatment of human HCC cells, including the stress-inducible nuclear protein 1 (NUPR1) gene. Multiple studies have shown that NUPR1 regulates autophagy, apoptosis, and chemoresistance. Here, we demonstrate that treatment of HCC cells with sorafenib resulted in the activation of autophagic flux. NUPR1 knock-down (KD) in HCC cells was associated with increased p62 expression, suggest…

SorafenibCancer ResearchCarcinoma HepatocellularSettore MED/09 - Medicina InternaHepatocellular carcinomap73Mice NudeApoptosisSettore BIO/11 - Biologia MolecolareMiceNSC5594In vivoPumaBasic Helix-Loop-Helix Transcription FactorsmedicineAutophagyNSC5994AnimalsHumansGene silencingneoplasmsbiologyActivator (genetics)business.industryLiver NeoplasmsAutophagyApoptosiTumor Protein p73Hep G2 CellsSorafenibbiology.organism_classificationmedicine.diseasedigestive system diseasesNeoplasm ProteinsOncologyDrug Resistance NeoplasmApoptosisHepatocellular carcinomaCancer researchFemalebusinessNUPR1medicine.drug
researchProduct

Highly Porous Wood Based Carbon Materials for Supercapacitors

2015

Wood based activated carbons synthesized by two-stage thermocatalytical synthesis with NaOH activator were studied and used as supercapacitor electrodes (sulphuric acid electrolyte). Porous structure and electrochemical properties of carbons vs synthesis conditions were assessed. It was found that there are correlations between carbons synthesis variables, their porosity and supercapacitors functional characteristics. At the temperature 600 o C and activator/precursor ratio 1.25 porosity decreased, however energy capacitance of supercapacitor increased calculating on elementary cell mass.

SupercapacitorMaterials scienceChemical engineeringAcid electrolyteActivator (phosphor)Highly porousElectrodeComposite materialElectrochemistryPorosityCapacitanceIOP Conference Series: Materials Science and Engineering
researchProduct

The Saccharomyces cerevisiae flavodoxin-like proteins Ycp4 and Rfs1 play a role in stress response and in the regulation of genes related to metaboli…

2011

SPI1 is a gene whose expression responds to many environmental stimuli, including entry into stationary phase. We have performed a screening to identify genes that activate SPI1 promoter when overexpressed. The phosphatidylinositol- 4-phosphate 5-kinase gene MSS4 was identified as a positive activator of SPI1. Another SPI1 transcriptional regulator isolated was the flavodoxin-like gene YCP4. YCP4 and its homolog RFS1 regulate the expression of many genes during the late stages of growth. The double deletion mutant in YCP4 and its homolog RFS1 has an impact on gene expression related to metabolism by increasing the expression of genes involved in hexose transport and glycolysis, and decreasi…

TBX1Saccharomyces cerevisiae Proteins[SDV]Life Sciences [q-bio]Genes FungalFlavodoxinSaccharomyces cerevisiae[SDV.BC]Life Sciences [q-bio]/Cellular BiologyBiologyBiochemistryMicrobiology03 medical and health sciencesGene Expression Regulation FungalGene expressionGeneticsTranscriptional regulationPromoter Regions GeneticMolecular BiologyGeneHexose transportComputingMilieux_MISCELLANEOUS030304 developmental biologyOligonucleotide Array Sequence AnalysisGenetics0303 health sciencesSPI1Membrane GlycoproteinsActivator (genetics)Gene Expression Profiling030302 biochemistry & molecular biologyRNA FungalGeneral Medicine3. Good healthOxidative StressPhosphotransferases (Alcohol Group Acceptor)FermentationMutationTranslational elongation
researchProduct

Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane

2005

We have previously shown that activation of PKC (protein kinase C) results in internalization of hCAT-1 [human CAT-1 (cationic amino acid transporter 1)] and a decrease in arginine transport [Rotmann, Strand, Martiné and Closs (2004) J. Biol. Chem. 279, 54185–54192]. However, others found increased transport rates for arginine in response to PKC activation, suggesting a differential effect of PKC on different CAT isoforms. Therefore we investigated the effect of PKC on hCAT-3, an isoform expressed in thymus, brain, ovary, uterus and mammary gland. In Xenopus laevis oocytes and human U373MG glioblastoma cells, hCAT-3-mediated L-arginine transport was significantly reduced upon treatment with…

TeratocarcinomaArginineXenopusDown-RegulationArginineBiochemistryEnzyme activatorAntibody SpecificityCell Line TumorTumor Cells CulturedAnimalsHumansMolecular BiologyProtein Kinase CProtein kinase CCationic Amino Acid Transporter 1Arginine transportbiologyActivator (genetics)Cell MembraneBiological TransportCell BiologyFusion proteinEnzyme ActivationBiochemistryTetradecanoylphorbol AcetateOocytesbiology.proteinTetradecanoylphorbol AcetateCATIONIC AMINO ACID TRANSPORTER 3GlioblastomaResearch ArticleBiochemical Journal
researchProduct

The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.

1999

Interleukin-6 (IL-6) triggers pivotal pathways in vivo. The designer protein hyper-IL-6 (H-IL-6) fuses the soluble IL-6 receptor (sIL-6R) through an intermediate linker with IL-6. The intracellular pathways that are triggered by H-IL-6 are not defined yet. Therefore, we studied the molecular mechanisms leading to H-IL-6-dependent gene activation. H-IL-6 stimulates haptoglobin mRNA expression in HepG2 cells, which is transcriptionally mediated as assessed by run-off experiments. The increase in haptoglobin gene transcription correlates with higher nuclear translocation of tyrosine-phosphorylated STAT3 and its DNA binding. As H-IL-6 stimulates STAT3-dependent gene transcription, we compared t…

Therapeutic gene modulationSTAT3 Transcription FactorTranscriptional ActivationTranscription GeneticRecombinant Fusion ProteinsResponse elementE-boxBiologyTransfectionBiochemistryCell LineMiceSp3 transcription factorAntigens CDCytokine Receptor gp130E2F1AnimalsHumansRNA MessengerPhosphorylationMolecular BiologyCell NucleusATF3Sp1 transcription factorMice Inbred C3HMembrane GlycoproteinsHaptoglobinsInterleukin-6Liver receptor homolog-1Biological TransportCell BiologyDNAReceptors InterleukinMolecular biologyReceptors Interleukin-6DNA-Binding ProteinsGene Expression RegulationTrans-ActivatorsTyrosineThe Journal of biological chemistry
researchProduct

Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes

2013

Abstract Background Organic cation transporter 1 (OCT1, SLC22A1) is a membrane transporter that is important for therapeutic effect of the antidiabetic drug metformin. Its liver-specific expression in hepatocytes is strongly controlled by hepatocyte nuclear factor-4α (HNF4α). HNF4α expression and transcriptional activity have been demonstrated to be augmented by glucocorticoid receptor (GR) in human hepatocytes and rodent livers. Methods It was examined whether GR activation indirectly induces OCT1 gene expression via HNF4α up-regulation in primary human hepatocytes.We also examined which other transcription factors are involved in OCT1 gene expression and whether they are regulated by dexa…

Time FactorsPrimary Cell CultureTransfectionDexamethasoneReceptors GlucocorticoidGlucocorticoid receptorTransduction GeneticEnhancer bindingCoactivatorGene expressionHumansRNA MessengerGlucocorticoidsTranscription factorPharmacologyRegulation of gene expressionChemistryCCAAT-Enhancer-Binding Protein-betaOrganic Cation Transporter 1Hep G2 CellsGeneral MedicineTransfectionPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaMolecular biologyUp-RegulationHepatocyte Nuclear Factor 4Cell cultureHepatocytesTranscription FactorsPharmacological Reports
researchProduct

Enzymatically hydrolyzed low-density lipoprotein modulates inflammatory responses in endothelial cells

2009

SummaryThere is evidence that low-density lipoprotein (LDL) is modified by hydrolytic enzymes,and that the product (E-LDL) induces selective production of interleukin 8 (IL-8) in endothelial cells. Since nuclear factor-kappaB (NF-κB) is a major regulator of IL-8 transcription, we studied its activation in endothelial cells treated with E-LDL. Unexpectedly,the modified lipoprotein not only failed to activate NF-κB, but completely blocked its activation by tumour necrosis factor-alpha (TNF-α) in EA.hy926-cells, as assessed by electrophoretic mobility shift assays and immunofluorescence. Inhibition occurred upstream of NF-κB translocation, as inhibitor of NF-κB- (IκB)-phosphorylation was suppr…

Time FactorsProto-Oncogene Proteins c-junPyridinesmedicine.medical_treatmentFatty Acids NonesterifiedBiologyp38 Mitogen-Activated Protein KinasesCell Linechemistry.chemical_compoundNF-KappaB Inhibitor alphamedicineHumansTrypsinInterleukin 8PhosphorylationPromoter Regions GeneticProtein Kinase InhibitorsTranscription factorInflammationTumor Necrosis Factor-alphaActivator (genetics)HydrolysisInterleukin-8ImidazolesTranscription Factor RelAEndothelial CellsNF-κBHematologySterol EsteraseMolecular biologyLipoproteins LDLTranscription Factor AP-1Endothelial stem cellCytokineBiochemistrychemistryLow-density lipoproteinI-kappa B ProteinsLipoproteinThrombosis and Haemostasis
researchProduct

Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhage.

2020

Abstract Objective Hematoma lysis with recombinant tissue plasminogen activator (rtPA) has emerged as an alternative therapy for spontaneous intracerebral and intraventricular haemorrhage (ICH and IVH). However, the MISTIE III and CLEAR III trial failed to show significant improvement of favourable outcomes. Besides experimental and clinical trials revealed neurotoxic effects of rtPA. The demand for optimization of fibrinolytic therapy persists. Herein, we used our recently devised clot model of ICH to systematically analyse fibrinolytic properties of rtPA, tenecteplase and urokinase. Methods In vitro clots of human blood (size: 25 ml and 50 ml; age: 1.5 tenecteplase, 24 tenecteplase and 48…

Time FactorsTenecteplase03 medical and health sciences0302 clinical medicineHematomaFibrinolytic AgentsmedicineHumansThrombolytic TherapyCerebral HemorrhageUrokinaseHuman bloodDose-Response Relationship Drugbusiness.industryOptimal treatmentFibrinolysisRehabilitationmedicine.diseaseUrokinase-Type Plasminogen ActivatorIn vitroCatheterAnesthesiaTissue Plasminogen ActivatorTenecteplaseSurgeryNeurology (clinical)Fibrinolytic therapyCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgerymedicine.drugJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct